nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR2C—metabolic syndrome X	0.763	1	CbGaD
Amoxapine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00948	0.104	CbGeAlD
Amoxapine—HTR7—sympathetic nervous system—metabolic syndrome X	0.00913	0.1	CbGeAlD
Amoxapine—HTR2A—arteriole—metabolic syndrome X	0.00894	0.0981	CbGeAlD
Amoxapine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00637	0.0699	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—metabolic syndrome X	0.00614	0.0674	CbGeAlD
Amoxapine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.0057	0.0625	CbGeAlD
Amoxapine—HTR1B—artery—metabolic syndrome X	0.00451	0.0496	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00383	0.042	CbGeAlD
Amoxapine—HTR1B—blood vessel—metabolic syndrome X	0.00352	0.0386	CbGeAlD
Amoxapine—HTR7—artery—metabolic syndrome X	0.00348	0.0382	CbGeAlD
Amoxapine—Olanzapine—FMO3—metabolic syndrome X	0.00328	0.383	CrCbGaD
Amoxapine—HTR7—endothelium—metabolic syndrome X	0.00294	0.0323	CbGeAlD
Amoxapine—HTR7—blood vessel—metabolic syndrome X	0.00271	0.0298	CbGeAlD
Amoxapine—HTR2A—artery—metabolic syndrome X	0.00217	0.0238	CbGeAlD
Amoxapine—HTR2A—endothelium—metabolic syndrome X	0.00183	0.0201	CbGeAlD
Amoxapine—Clozapine—FMO3—metabolic syndrome X	0.00171	0.2	CrCbGaD
Amoxapine—HTR2A—blood vessel—metabolic syndrome X	0.00169	0.0186	CbGeAlD
Amoxapine—HTR1B—cardiovascular system—metabolic syndrome X	0.00157	0.0172	CbGeAlD
Amoxapine—CHRM1—cardiovascular system—metabolic syndrome X	0.00142	0.0156	CbGeAlD
Amoxapine—HTR2B—cardiovascular system—metabolic syndrome X	0.00141	0.0155	CbGeAlD
Amoxapine—HTR1A—cardiovascular system—metabolic syndrome X	0.00127	0.0139	CbGeAlD
Amoxapine—HTR2B—adipose tissue—metabolic syndrome X	0.00125	0.0137	CbGeAlD
Amoxapine—Asenapine—HTR2C—metabolic syndrome X	0.00123	0.144	CrCbGaD
Amoxapine—HTR7—cardiovascular system—metabolic syndrome X	0.00121	0.0133	CbGeAlD
Amoxapine—HTR7—kidney—metabolic syndrome X	0.00118	0.013	CbGeAlD
Amoxapine—ADRA1A—cardiovascular system—metabolic syndrome X	0.00117	0.0128	CbGeAlD
Amoxapine—ORM1—liver—metabolic syndrome X	0.00103	0.0114	CbGeAlD
Amoxapine—ADRA1A—adipose tissue—metabolic syndrome X	0.00103	0.0113	CbGeAlD
Amoxapine—HRH1—adipose tissue—metabolic syndrome X	0.000797	0.00874	CbGeAlD
Amoxapine—ADRA2A—adipose tissue—metabolic syndrome X	0.000782	0.00859	CbGeAlD
Amoxapine—HTR2A—cardiovascular system—metabolic syndrome X	0.000754	0.00828	CbGeAlD
Amoxapine—HTR7—liver—metabolic syndrome X	0.000748	0.00821	CbGeAlD
Amoxapine—HTR2A—kidney—metabolic syndrome X	0.000738	0.0081	CbGeAlD
Amoxapine—ADRA1A—liver—metabolic syndrome X	0.000722	0.00792	CbGeAlD
Amoxapine—Olanzapine—HTR2C—metabolic syndrome X	0.000683	0.0798	CrCbGaD
Amoxapine—CYP2D6—kidney—metabolic syndrome X	0.000672	0.00738	CbGeAlD
Amoxapine—HTR2A—liver—metabolic syndrome X	0.000467	0.00512	CbGeAlD
Amoxapine—CYP2D6—liver—metabolic syndrome X	0.000425	0.00467	CbGeAlD
Amoxapine—Loxapine—HTR2C—metabolic syndrome X	0.000424	0.0496	CrCbGaD
Amoxapine—Quetiapine—HTR2C—metabolic syndrome X	0.000414	0.0484	CrCbGaD
Amoxapine—Clozapine—HTR2C—metabolic syndrome X	0.000356	0.0417	CrCbGaD
Amoxapine—Olanzapine—ALB—metabolic syndrome X	0.000298	0.0348	CrCbGaD
Amoxapine—Diazepam—ALB—metabolic syndrome X	0.000157	0.0184	CrCbGaD
Amoxapine—DRD4—Signaling Pathways—IGF1—metabolic syndrome X	1.61e-05	0.000117	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.61e-05	0.000117	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CD36—metabolic syndrome X	1.61e-05	0.000117	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—SERPINE1—metabolic syndrome X	1.6e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—SERPINE1—metabolic syndrome X	1.6e-05	0.000116	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	1.59e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	1.59e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—INS—metabolic syndrome X	1.59e-05	0.000116	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL5—metabolic syndrome X	1.59e-05	0.000115	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.58e-05	0.000115	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL5—metabolic syndrome X	1.58e-05	0.000115	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.58e-05	0.000115	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—LPL—metabolic syndrome X	1.58e-05	0.000115	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.58e-05	0.000115	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.58e-05	0.000115	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.58e-05	0.000115	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IRS1—metabolic syndrome X	1.56e-05	0.000114	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-05	0.000114	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	1.56e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	1.55e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.55e-05	0.000113	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—LPL—metabolic syndrome X	1.55e-05	0.000113	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.55e-05	0.000113	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—LPL—metabolic syndrome X	1.55e-05	0.000112	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IRS1—metabolic syndrome X	1.54e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	1.54e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF1—metabolic syndrome X	1.54e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.53e-05	0.000111	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SERPINE1—metabolic syndrome X	1.53e-05	0.000111	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NOS3—metabolic syndrome X	1.53e-05	0.000111	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	1.53e-05	0.000111	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NOS3—metabolic syndrome X	1.52e-05	0.000111	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	1.52e-05	0.000111	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	1.51e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	1.51e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.5e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.5e-05	0.000109	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—INS—metabolic syndrome X	1.5e-05	0.000109	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PPARA—metabolic syndrome X	1.49e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	1.49e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.48e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NOS3—metabolic syndrome X	1.48e-05	0.000108	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	1.48e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—INS—metabolic syndrome X	1.48e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCL2—metabolic syndrome X	1.47e-05	0.000107	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NOS3—metabolic syndrome X	1.46e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.46e-05	0.000106	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCL2—metabolic syndrome X	1.45e-05	0.000106	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF1—metabolic syndrome X	1.45e-05	0.000105	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AGT—metabolic syndrome X	1.45e-05	0.000105	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	1.45e-05	0.000105	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.44e-05	0.000105	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF1—metabolic syndrome X	1.43e-05	0.000104	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.42e-05	0.000103	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.41e-05	0.000103	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-05	0.000101	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.38e-05	0.0001	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.36e-05	9.89e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.36e-05	9.89e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.36e-05	9.88e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.35e-05	9.83e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.35e-05	9.78e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.34e-05	9.73e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.33e-05	9.67e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AGT—metabolic syndrome X	1.33e-05	9.65e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.32e-05	9.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.32e-05	9.63e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AGT—metabolic syndrome X	1.32e-05	9.62e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NOS3—metabolic syndrome X	1.31e-05	9.56e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.31e-05	9.52e-05	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—AKT1—metabolic syndrome X	1.31e-05	9.51e-05	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—AKT1—metabolic syndrome X	1.31e-05	9.5e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.3e-05	9.48e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.3e-05	9.48e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	9.47e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.3e-05	9.45e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.3e-05	9.45e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.3e-05	9.43e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	1.3e-05	9.42e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	1.3e-05	9.42e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.29e-05	9.37e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.29e-05	9.37e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—metabolic syndrome X	1.29e-05	9.36e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—metabolic syndrome X	1.29e-05	9.35e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.29e-05	9.35e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.28e-05	9.32e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	1.28e-05	9.32e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—metabolic syndrome X	1.28e-05	9.3e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.28e-05	9.28e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.28e-05	9.28e-05	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.27e-05	9.24e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.27e-05	9.22e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.26e-05	9.17e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	9.17e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	1.25e-05	9.1e-05	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.25e-05	9.1e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.25e-05	9.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.24e-05	9.02e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.23e-05	8.98e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.23e-05	8.95e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.21e-05	8.81e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.21e-05	8.8e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.2e-05	8.76e-05	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-05	8.68e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	1.19e-05	8.64e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	1.19e-05	8.63e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.19e-05	8.62e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.19e-05	8.62e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.18e-05	8.61e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.18e-05	8.59e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—AKT1—metabolic syndrome X	1.18e-05	8.58e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.18e-05	8.56e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	1.18e-05	8.55e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.17e-05	8.52e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.16e-05	8.45e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.16e-05	8.43e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	1.16e-05	8.41e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	1.15e-05	8.39e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.15e-05	8.39e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	8.28e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	1.14e-05	8.26e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.13e-05	8.23e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.13e-05	8.22e-05	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.13e-05	8.19e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.12e-05	8.17e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.12e-05	8.16e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.11e-05	8.09e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.11e-05	8.09e-05	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	1.11e-05	8.08e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—INS—metabolic syndrome X	1.11e-05	8.08e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.11e-05	8.07e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	1.11e-05	8.06e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—INS—metabolic syndrome X	1.11e-05	8.05e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.1e-05	8.01e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.1e-05	7.96e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.09e-05	7.96e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	1.09e-05	7.95e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	7.95e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	7.93e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	7.92e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-05	7.88e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.08e-05	7.83e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	7.81e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	7.8e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	7.79e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.06e-05	7.72e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.06e-05	7.69e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	7.67e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.05e-05	7.61e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.04e-05	7.56e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	1.02e-05	7.44e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.02e-05	7.44e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.02e-05	7.42e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.02e-05	7.4e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.01e-05	7.36e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	1.01e-05	7.34e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	1.01e-05	7.34e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	1.01e-05	7.33e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1e-05	7.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	9.96e-06	7.25e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	9.92e-06	7.21e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	9.81e-06	7.13e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	9.79e-06	7.12e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.76e-06	7.1e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	9.74e-06	7.08e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.73e-06	7.08e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	9.71e-06	7.06e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	9.71e-06	7.06e-05	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.68e-06	7.04e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	9.65e-06	7.02e-05	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.63e-06	7e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	9.56e-06	6.95e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	9.53e-06	6.93e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.48e-06	6.9e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AGT—metabolic syndrome X	9.43e-06	6.86e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.3e-06	6.76e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.24e-06	6.72e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	9.21e-06	6.7e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	9.13e-06	6.64e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	8.88e-06	6.46e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.79e-06	6.39e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.75e-06	6.36e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	8.69e-06	6.32e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	8.57e-06	6.23e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.5e-06	6.18e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	8.37e-06	6.09e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.36e-06	6.08e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.35e-06	6.07e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.32e-06	6.05e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.23e-06	5.99e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	8.22e-06	5.97e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.19e-06	5.96e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	8.19e-06	5.96e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	8.06e-06	5.86e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	8.05e-06	5.85e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—metabolic syndrome X	7.89e-06	5.74e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	7.72e-06	5.61e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.61e-06	5.53e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	7.61e-06	5.53e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—metabolic syndrome X	7.6e-06	5.52e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.6e-06	5.52e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	7.58e-06	5.51e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	7.55e-06	5.49e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	7.49e-06	5.45e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.47e-06	5.43e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.44e-06	5.41e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.43e-06	5.41e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	7.39e-06	5.37e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—metabolic syndrome X	7.27e-06	5.29e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.23e-06	5.26e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	7.02e-06	5.1e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	7.01e-06	5.1e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	6.94e-06	5.05e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.92e-06	5.03e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.91e-06	5.03e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	6.82e-06	4.96e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	6.71e-06	4.88e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	6.56e-06	4.77e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—metabolic syndrome X	6.55e-06	4.76e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—metabolic syndrome X	6.46e-06	4.7e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.45e-06	4.69e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	6.44e-06	4.68e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	6.42e-06	4.67e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	6.4e-06	4.66e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.33e-06	4.6e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.32e-06	4.6e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	6.04e-06	4.39e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	5.96e-06	4.33e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.87e-06	4.27e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.63e-06	4.09e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.6e-06	4.07e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.19e-06	3.78e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.17e-06	3.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.94e-06	3.59e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.88e-06	3.55e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.86e-06	3.54e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.85e-06	3.53e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	4.84e-06	3.52e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.76e-06	3.46e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.56e-06	3.32e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.49e-06	3.26e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.48e-06	3.26e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	4.46e-06	3.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.42e-06	3.22e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.39e-06	3.2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4.08e-06	2.97e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.18e-06	2.31e-05	CbGpPWpGaD
